Michael Gleeson, SVP, Corporate Accounts at GenMark Diagnostics, Inc. (GNMK), sold 40,198 shares at $5.60 ($225K) on 2019-11-26, disclosed to the SEC on 2019-11-27.
Seasonal sale ($225k) by SVP, Corporate Accounts — this insider has traded GNMK in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.60 | 20,099 | $113K | 50.0% |
| 2 | $5.60 | 20,099 | $113K | 50.0% |
| Total | $5.60 avg | 40,198 | $225K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-22 | $51K | — | Filing → |
| GNMK | SELL | 2021-01-25 | $939K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $43K | — | Filing → |